119 related articles for article (PubMed ID: 1693042)
1. Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome.
Nielsen JB; Lou HC; Andresen J
Brain Dev; 1990; 12(1):143-7. PubMed ID: 1693042
[TBL] [Abstract][Full Text] [Related]
2. CSF and urine biogenic amine metabolites in Rett syndrome.
Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B
Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058
[TBL] [Abstract][Full Text] [Related]
3. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
Nielsen JB; Bertelsen A; Lou HC
Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
[TBL] [Abstract][Full Text] [Related]
4. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
5. Central monoamines and hyperkinase of childhood.
Shetty T; Chase TN
Neurology; 1976 Oct; 26(10):1000-2. PubMed ID: 986582
[TBL] [Abstract][Full Text] [Related]
6. Neuroamine related compounds in the CSF of hydrocephalic rabbits.
Olmstead CE; Lazareff JA; Orlino EN; Fluharty AL; Faull KF; Peacock WJ; Wehby-Grant MC; Gayek RJ; Fisher RS
Neuroreport; 1995 Sep; 6(13):1769-72. PubMed ID: 8541478
[TBL] [Abstract][Full Text] [Related]
7. Dopamine and serotonin metabolism in hepatic encephalopathy.
Knell AJ; Davidson AR; Williams R; Kantamaneni BD; Curzon G
Br Med J; 1974 Mar; 1(5907):549-51. PubMed ID: 4817189
[TBL] [Abstract][Full Text] [Related]
8. Brain transmitter precursors and metabolites in diabetic ketoacidosis.
Curzon G; Kantamaneni BD; Callaghan N; Sullivan PA
J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):489-93. PubMed ID: 6181209
[TBL] [Abstract][Full Text] [Related]
9. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
10. Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat.
Chaouloff F; Laude D; Guezennec Y; Elghozi JL
J Neurochem; 1986 Apr; 46(4):1313-6. PubMed ID: 2419509
[TBL] [Abstract][Full Text] [Related]
11. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
[TBL] [Abstract][Full Text] [Related]
12. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
Takahashi S; Abe T
No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Temudo T; Rios M; Prior C; Carrilho I; Santos M; Maciel P; Sequeiros J; Fonseca M; Monteiro J; Cabral P; Vieira JP; Ormazabal A; Artuch R
Brain Dev; 2009 Jan; 31(1):46-51. PubMed ID: 18572337
[TBL] [Abstract][Full Text] [Related]
14. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
[TBL] [Abstract][Full Text] [Related]
15. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
16. Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment.
Burlina AB; Bonafé L; Ferrari V; Suppiej A; Zacchello F; Burlina AP
J Inherit Metab Dis; 2000 Jun; 23(4):313-6. PubMed ID: 10896282
[No Abstract] [Full Text] [Related]
17. Tryptophan therapy for non-ketotic hyperglycinaemia.
Inoue F; Matsuo S; Yoshioka H; Takeuchi Y; Yamanaka H; Kodo N; Kinugasa A; Sawada T
J Inherit Metab Dis; 1992; 15(3):399-401. PubMed ID: 1383606
[No Abstract] [Full Text] [Related]
18. A comparison of D and L-tryptophan on the cerebral metabolism of 5-hydroxytryptamine and dopamine in the dog.
Budny J; Dow RC; Eccleston D; Hill AG; Ritchie IM
Br J Pharmacol; 1976 Sep; 58(1):3-7. PubMed ID: 974375
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variability.
Riddle MA; Anderson GM; McIntosh S; Harcherik DF; Shaywitz BA; Cohen DJ
Biol Psychiatry; 1986 Jan; 21(1):69-83. PubMed ID: 2417634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
